Skip to main content
SpringerLink
Log in

Challenges in the Management of Inflammatory Bowel Disease

  • Living reference work entry
  • First Online:
Book cover Geriatric Gastroenterology

Abstract

The initial approach to the management of IBD in the elderly requires authentication of the IBD diagnosis recognizing the potential for confounding multiple diagnosis, e.g., ischemia, radiation, segmental colitis with diverticulitis disease, NSAID use, and GI infection, and multiple comorbidities such as COPD, heart disease, chronic kidney disease, and vascular disease. Further, impact on management along with the need for distinguishing the “fit from frail” elderly helps drive therapeutic decisions. Clinical symptom improvement takes precedence over deep remission, i.e., endoscopic, histologic, and biomarker remission. The overarching threat of infection is of paramount concern and mandates vigilance in maintaining an updated vaccination schedule.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Abbas AM, et al. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort. Am J Gastroenterol. 2014;109(11):1781–93.

    Article  CAS  PubMed  Google Scholar 

  • Administration on Aging. Census data on aging [online]. 2010; 2011.

    Google Scholar 

  • AG A. Adult inflammatory bowel disease physician performance measures set. 2011.

    Google Scholar 

  • Akerkar GA, et al. Corticosteroid-associated complications in elderly Crohn’s disease patients. Am J Gastroenterol. 1997;92(3):461–4.

    CAS  PubMed  Google Scholar 

  • Alcain G, et al. Acute leukemia after infliximab therapy. Am J Gastroenterol. 2003;98(11):2577.

    Article  PubMed  Google Scholar 

  • Aldhous MC, et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol. 2007;102(3):589–97.

    Article  PubMed  Google Scholar 

  • Alexakis C, et al. Do thiopurines reduce the risk of surgery in elderly onset inflammatory bowel disease? A 20-year National Population-Based Cohort Study. Inflamm Bowel Dis. 2017;23(4):672–80.

    Article  PubMed  Google Scholar 

  • Almogy G, et al. Surgery for ulcerative colitis in elderly persons: changes in indications for surgery and outcome over time. Arch Surg. 2001;136(12):1396–400.

    Article  CAS  PubMed  Google Scholar 

  • Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis. 2013;7(2):107–12.

    Article  PubMed  Google Scholar 

  • Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57(2):205–10.

    Article  CAS  PubMed  Google Scholar 

  • Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009;15(2):182–9.

    Article  PubMed  Google Scholar 

  • Ananthakrishnan AN, et al. Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases. Aliment Pharmacol Ther. 2015;41(11):1141–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ananthakrishnan AN, et al. Systematic review and meta-analysis: phenotype and clinical outcomes of older-onset inflammatory bowel disease. J Crohns Colitis. 2016;10(10):1224–36.

    Article  PubMed  PubMed Central  Google Scholar 

  • Axelrad J, et al. Risk of new or recurrent Cancer in patients with inflammatory bowel disease and previous Cancer exposed to immunosuppressive and anti-tumor necrosis factor agents. Clin Gastroenterol Hepatol. 2016;14(1):58–64.

    Article  CAS  PubMed  Google Scholar 

  • Axelrad JE, et al. Hormone therapy for cancer is a risk factor for relapse of inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2019. pii: S1542-3565(19)30735-9. https://doi.org/10.1016/j.cgh.2019.06.042. [Epub ahead of print].

  • Beaugerie L. Excess risk of lymphoproliferative disorder (LPD) in inflammatory bowel disease (IBD): interim results of the CESAME cohort. Gastroenerol. 2008;134:A116–7.

    Article  Google Scholar 

  • Beaugerie L, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374(9701):1617–25.

    Article  CAS  PubMed  Google Scholar 

  • Beaugerie L, et al. Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer. Gut. 2014;63(9):1416–23.

    Article  PubMed  Google Scholar 

  • Beldon P. Incontinence-associated dermatitis: protecting the older person. Br J Nurs. 2012;21(7):402, 404–7.

    Article  Google Scholar 

  • Benchimol EI, et al. International variation in medication prescription rates among elderly patients with inflammatory bowel disease. J Crohns Colitis. 2013;7(11):878–89.

    Article  PubMed  Google Scholar 

  • Bernheim O, et al. The management of immunosuppression in patients with inflammatory bowel disease and cancer. Gut. 2013;62(11):1523–8.

    Article  CAS  PubMed  Google Scholar 

  • Biagi E, et al. Aging of the human metaorganism: the microbial counterpart. Age (Dordr). 2012;34(1):247–67.

    Article  Google Scholar 

  • Bickston SJ, et al. The relationship between infliximab treatment and lymphoma in Crohn’s disease. Gastroenterology. 1999;117(6):1433–7.

    Article  CAS  PubMed  Google Scholar 

  • Bilyard KG, Joseph EC, Metcalf R. Mesalazine: an overview of key preclinical studies. Scand J Gastroenterol Suppl. 1990;172:52–5.

    Article  CAS  PubMed  Google Scholar 

  • Blackburn D, Hux J, Mamdani M. Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly. J Gen Intern Med. 2002;17(9):717–20.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bollegala N, Jackson TD, Nguyen GC. Increased postoperative mortality and complications among elderly patients with inflammatory bowel diseases: an analysis of the National Surgical Quality Improvement Program Cohort. Clin Gastroenterol Hepatol. 2016;14(9):1274–81.

    Article  PubMed  Google Scholar 

  • Bonovas S, et al. Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis. Clin Gastroenterol Hepatol. 2016;14(10):1385–1397 e10.

    Article  PubMed  Google Scholar 

  • Botoman VA, Bonner GF, Botoman DA. Management of inflammatory bowel disease. Am Fam Physician. 1998;57(1):57–68.. 71-2

    CAS  PubMed  Google Scholar 

  • Boult C, et al. Successful models of comprehensive care for older adults with chronic conditions: evidence for the Institute of Medicine’s “retooling for an aging America” report. J Am Geriatr Soc. 2009;57(12):2328–37.

    Article  PubMed  Google Scholar 

  • Boyko EJ, et al. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med. 1987;316(12):707–10.

    Article  CAS  PubMed  Google Scholar 

  • Brassard P, et al. Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases. Am J Gastroenterol. 2014;109(11):1795–802; quiz 1803.

    Article  CAS  PubMed  Google Scholar 

  • Bressler B, et al. Clinicians’ guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease. Can J Gastroenterol Hepatol. 2015;29(7):369–72.

    Article  PubMed  PubMed Central  Google Scholar 

  • Britton E, McLaughlin JT. Ageing and the gut. Proc Nutr Soc. 2013;72(1):173–7.

    Article  PubMed  Google Scholar 

  • Brown SL, et al. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum. 2002;46(12):3151–8.

    Article  CAS  PubMed  Google Scholar 

  • Burden of digestive diseases in the United States. NIH Publication 2013 [cited No. 09-6443. 2008. Available from: http://www2.niddk.nih.gov/AboutNIDDK/REportsAndStrategicPlanning/

  • Calder PC. Feeding the immune system. Proc Nutr Soc. 2013;72(3):299–309.

    Article  PubMed  Google Scholar 

  • Cambier J. Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling. Immunol Rev. 2005;205:5–6.

    Article  PubMed  Google Scholar 

  • Chandar AK, et al. Efficacy and safety of Natalizumab and Vedolizumab for the Management of Crohn's disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2015;21(7):1695–708.

    Article  PubMed  Google Scholar 

  • Charpentier C, et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014;63(3):423–32.

    Article  PubMed  Google Scholar 

  • Cheddani H, et al. Cancer in elderly onset inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2016;111(10):1428–36.

    Article  PubMed  Google Scholar 

  • Claesson MJ, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A. 2011;108(1):4586–91.

    Article  CAS  PubMed  Google Scholar 

  • Clegg A, et al. Frailty in elderly people. Lancet. 2013;381(9868):752–62.

    Article  PubMed  Google Scholar 

  • Cohan JN, et al. Outcomes after ileoanal pouch surgery in frail and older adults. J Surg Res. 2015;198(2):327–33.

    Article  PubMed  Google Scholar 

  • Colombel JF, et al. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy. Aliment Pharmacol Ther. 2017a;45(1):50–62.

    Article  CAS  PubMed  Google Scholar 

  • Colombel JF, et al. The safety of vedolizumab for ulcerative colitis and Crohn's disease. Gut. 2017b;66(5):839–51.

    Article  CAS  PubMed  Google Scholar 

  • Cosnes J, et al. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology. 1996;110(2):424–31.

    Article  CAS  PubMed  Google Scholar 

  • Cottone M, et al. Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9(1):30–5.

    Article  CAS  PubMed  Google Scholar 

  • Cucchiara S, et al. The microbiota in inflammatory bowel disease in different age groups. Dig Dis. 2009;27(3):252–8.

    Article  PubMed  Google Scholar 

  • Delaney CP, et al. Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis. Ann Surg. 2002a;236(1):43–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Delaney CP, et al. Functional outcome, quality of life, and complications after ileal pouch-anal anastomosis in selected septuagenarians. Dis Colon Rectum. 2002b;45(7):890–4; discussion 894.

    Article  PubMed  Google Scholar 

  • Delaney CP, et al. Prospective, age-related analysis of surgical results, functional outcome, and quality of life after ileal pouch-anal anastomosis. Ann Surg. 2003;238(2):221–8.

    PubMed  PubMed Central  Google Scholar 

  • Desai A, et al. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(2):309–15.

    Article  PubMed  Google Scholar 

  • Dharmasiri S, Johnson H, McLaughlin S, Weaver S. PTU-109, Azathioprine in the elderly – is it tolerated and is it safe? Gut. 2014;63(1):A87.

    Google Scholar 

  • Ding T, et al. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. Rheumatology (Oxford). 2010;49(11):2217–9.

    Article  Google Scholar 

  • Duricova D, et al. Extra-intestinal manifestations at diagnosis in Paediatric- and elderly-onset ulcerative colitis are associated with a more severe disease outcome: a population-based study. J Crohns Colitis. 2017;11(11):1326–34.

    Article  PubMed  Google Scholar 

  • Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Everhov AH, et al. Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden. Gastroenterology. 2018;154(3):518–528 e15.

    Article  PubMed  Google Scholar 

  • Fessler J, et al. The impact of aging on regulatory T-cells. Front Immunol. 2013;4:231.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Franceschi C, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128(1):92–105.

    Article  CAS  PubMed  Google Scholar 

  • Froslie KF, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133(2):412–22.

    Article  PubMed  Google Scholar 

  • Geisz M, et al. Medication utilization and the impact of continued corticosteroid use on patient-reported outcomes in older patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(6):1435–41.

    Article  PubMed  Google Scholar 

  • Gensini GF, Rostagno C, Caciolli S. Treatment options for acute venous thromboembolism in the older patient. Geriatrics. 1998;53(1):34–6, 39–40, 46–7.

    CAS  PubMed  Google Scholar 

  • Gisbert JP, Gonzalez-Lama Y, Mate J. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2007a;13(5):629–38.

    Article  PubMed  Google Scholar 

  • Gisbert JP, et al. Thiopurine methyltransferase activity in Spain: a study of 14,545 patients. Dig Dis Sci. 2007b;52(5):1262–9.

    Article  CAS  PubMed  Google Scholar 

  • Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375(9715):657–63.

    Article  PubMed  Google Scholar 

  • Guigoz Y, Dore J, Schiffrin EJ. The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care. 2008;11(1):13–20.

    Article  PubMed  Google Scholar 

  • Gupta S, et al. Effect of age on molecular signaling of TNF-alpha-induced apoptosis in human lymphocytes. Mech Ageing Dev. 2003;124(4):503–9.

    Article  CAS  PubMed  Google Scholar 

  • Parian AH, Ha CY. Severe polypharmacy and major medication interactions are associated with increasing age and comorbidity among inflammatory bowel disease patients [abstract Su1130]. Gastroenterology. 2013;144(1):S11.

    Article  Google Scholar 

  • Ha C, Dassopoulos T. Thiopurine therapy in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010;4(5):575–88.

    Article  CAS  PubMed  Google Scholar 

  • Ha CY, et al. Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. Clin Gastroenterol Hepatol. 2010;8(8):682–687 e1.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ha CY, Bayless TM, Wick E. Increased incidence of post-operative complications in older inflammatory bowel disease patients having intestinal surgery. Gastroenerology. 2012;142(1):S25.

    Article  Google Scholar 

  • Ha C, Bayless T, Wick E. In-hospital morbidity among older inflammatory bowel disease patients having intestinal surgery is predicted by the simplified comorbidity score and functional status [abstract 1009]. Gastroenerology. 2013;144(1):S189.

    Article  Google Scholar 

  • Hanlon JT, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.

    Article  CAS  PubMed  Google Scholar 

  • Hazlewood GS, et al. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn’s disease: a network meta-analysis. Gastroenterology. 2015;148(2):344–54 e5; quiz e14-5.

    Article  CAS  PubMed  Google Scholar 

  • Johnson SL, et al. Biological and steroid use in relationship to quality measures in older patients with inflammatory bowel disease: a US Medicare cohort study. BMJ Open. 2015;5(9):e008597.

    Article  PubMed  PubMed Central  Google Scholar 

  • Juneja M, et al. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci. 2012;57(9):2408–15.

    Article  PubMed  Google Scholar 

  • Kaplan GG, et al. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology. 2008;134(3):680–7.

    Article  PubMed  Google Scholar 

  • Kaplan GG, et al. Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease. Arch Surg. 2011;146(8):959–64.

    Article  PubMed  Google Scholar 

  • Kappelman MD, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5(12):1424–9.

    Article  PubMed  Google Scholar 

  • Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol. 2011;106(11):1889–97.

    Article  PubMed  Google Scholar 

  • Katz S, Surawicz C, Pardi DS. Management of the elderly patients with inflammatory bowel disease: practical considerations. Inflamm Bowel Dis. 2013;19(10):2257–72.

    Article  PubMed  Google Scholar 

  • Kaufman DW, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337–44.

    Article  PubMed  Google Scholar 

  • Khan N, et al. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study. Gastroenterology. 2013;145(5):1007–1015 e3.

    Article  CAS  PubMed  Google Scholar 

  • Khan N, et al. Risk of malignancy in a Nationwide cohort of elderly inflammatory bowel disease patients. Drugs Aging. 2017;34(11):859–68.

    Article  PubMed  PubMed Central  Google Scholar 

  • Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67–76.

    Article  CAS  PubMed  Google Scholar 

  • Kochar B, et al. Inflammatory bowel disease is similar in patients with older onset and younger onset. Inflamm Bowel Dis. 2017;23(7):1187–94.

    Article  PubMed  Google Scholar 

  • Kotlyar DS, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2015;13(5):847–58 e4; quiz e48–50.

    Article  CAS  PubMed  Google Scholar 

  • Kuypers DR. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Drugs Aging. 2009;26(9):715–37.

    Article  CAS  PubMed  Google Scholar 

  • Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol. 1992;43(4):329–39.

    Article  CAS  PubMed  Google Scholar 

  • Lichtenstein GR, et al. Management of Crohn's disease in adults. Am J Gastroenterol. 2009;104(2):465–83; quiz 464, 484.

    Article  PubMed  Google Scholar 

  • Lichtenstein GR, et al. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol. 2012;107(9):1409–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lichtenstein GR, et al. Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT registry. Am J Gastroenterol. 2014;109(2):212–23.

    Article  CAS  PubMed  Google Scholar 

  • Lin OS. Performing colonoscopy in elderly and very elderly patients: risks, costs and benefits. World J Gastrointest Endosc. 2014;6(6):220–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5(2):133–9.

    Article  CAS  PubMed  Google Scholar 

  • Lobaton T, et al. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42(4):441–51.

    Article  CAS  PubMed  Google Scholar 

  • Loftus EV Jr, et al. Crohn's disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology. 1998;114(6):1161–8.

    Article  PubMed  Google Scholar 

  • Loftus EV Jr, et al. Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut. 2000;46(3):336–43.

    Article  PubMed  PubMed Central  Google Scholar 

  • Loftus CG, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007;13(3):254–61.

    Article  PubMed  Google Scholar 

  • Long MD, et al. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143(2):390–399 e1.

    Article  PubMed  Google Scholar 

  • Lunney PC, Leong RW. Review article: ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther. 2012;36(11–12):997–1008.

    Article  CAS  PubMed  Google Scholar 

  • Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Manosa M, et al. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study. Aliment Pharmacol Ther. 2018;47(5):605–14.

    Article  CAS  PubMed  Google Scholar 

  • Marin-Jimenez I, Pena AS. Budesonide for ulcerative colitis. Rev Esp Enferm Dig. 2006;98(5):362–73.

    Article  CAS  PubMed  Google Scholar 

  • Mark-Christensen A, et al. Increasing incidence of pelvic sepsis following ileal pouch-anal anastomosis for ulcerative colitis in Denmark: a nationwide cohort study. Dis Colon Rectum. 2019;62(8):965–71.

    Article  PubMed  Google Scholar 

  • Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis. 2009;15(9):1410–6.

    Article  PubMed  Google Scholar 

  • Mocko P, Kawalec P, Pilc A. Safety profile of biologic drugs in the therapy of ulcerative colitis: a systematic review and network meta-analysis. Pharmacotherapy. 2016;36(8):870–9.

    Article  CAS  PubMed  Google Scholar 

  • Molodecky NA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54 e42; quiz e30.

    Article  PubMed  Google Scholar 

  • Morganstern B, Singh N, Targan S, et al. Single-center experience of vedolizumab in patients with inflammatory bowel disease: does age matter? Gastroenterology. 2015;148(1):S250.

    Article  Google Scholar 

  • Moscandrew M, Mahadevan U, Kane S. General health maintenance in IBD. Inflamm Bowel Dis. 2009;15(9):1399–409.

    Article  PubMed  Google Scholar 

  • Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103(9):2272–80.

    Article  PubMed  Google Scholar 

  • Nguyen GC, Bernstein CN, Benchimol EI. Risk of surgery and mortality in elderly-onset inflammatory bowel disease: a population-based cohort study. Inflamm Bowel Dis. 2017;23(2):218–23.

    Article  PubMed  Google Scholar 

  • Nguyen NH, et al. Infections and cardiovascular complications are common causes for hospitalization in older patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2018;24(4):916–23.

    Article  PubMed  Google Scholar 

  • Nunes T, et al. Smoking does influence disease behaviour and impacts the need for therapy in Crohn’s disease in the biologic era. Aliment Pharmacol Ther. 2013a;38(7):752–60.

    Article  CAS  PubMed  Google Scholar 

  • Nunes T, et al. Does smoking influence Crohn’s disease in the biologic era? The TABACROHN study. Inflamm Bowel Dis. 2013b;19(1):23–9.

    Article  PubMed  Google Scholar 

  • Nyboe Andersen N, et al. Association between tumor necrosis factor-alpha antagonists and risk of cancer in patients with inflammatory bowel disease. JAMA. 2014;311(23):2406–13.

    Article  PubMed  CAS  Google Scholar 

  • Ordas I, et al. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. Clin Pharmacol Ther. 2012a;91(4):635–46.

    Article  CAS  PubMed  Google Scholar 

  • Ordas I, Feagan BG, Sandborn WJ. Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2012b;10(10):1079–87.

    Article  CAS  PubMed  Google Scholar 

  • Page MJ, et al. Factors affecting surgical risk in elderly patients with inflammatory bowel disease. J Gastrointest Surg. 2002;6(4):606–13.

    Article  PubMed  Google Scholar 

  • Perlan AH, Ha CY. Severe polypharmacy and major medication interactions are associated with increasing age and comorbidity among inflammatory bowel disease patients. Gastroenerology. 2013;144(1):S11.

    Article  Google Scholar 

  • Pettersson B, et al. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate. Ther Drug Monit. 2002;24(3):351–8.

    Article  CAS  PubMed  Google Scholar 

  • Peyrin-Biroulet L, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology. 2011;141(5):1621–28 e1-5.

    Article  CAS  PubMed  Google Scholar 

  • Peyrin-Biroulet L, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for Treat-to-target. Am J Gastroenterol. 2015;110(9):1324–38.

    Article  CAS  PubMed  Google Scholar 

  • Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315(7115):1096–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roman AL, Munoz F. Comorbidity in inflammatory bowel disease. World J Gastroenterol. 2011;17(22):2723–33.

    Article  PubMed  PubMed Central  Google Scholar 

  • Roseth AG, Aadland E, Grzyb K. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol. 2004;39(10):1017–20.

    Article  CAS  PubMed  Google Scholar 

  • Ross H, et al. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum. 2014;57(1):5–22.

    Article  PubMed  Google Scholar 

  • Rutgeerts P, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990;99(4):956–63.

    Article  CAS  PubMed  Google Scholar 

  • Sahasranaman S, Howard D, Roy S. Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol. 2008;64(8):753–67.

    Article  CAS  PubMed  Google Scholar 

  • Schiffrin EJ, et al. The inflammatory status of the elderly: the intestinal contribution. Mutat Res. 2010;690(1–2):50–6.

    Article  CAS  PubMed  Google Scholar 

  • Schneeweiss S, et al. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007;56(6):1754–64.

    Article  CAS  PubMed  Google Scholar 

  • Schneeweiss S, et al. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther. 2009;30(3):253–64.

    Article  CAS  PubMed  Google Scholar 

  • Schreiber S, et al. Maintenance therapy with certolizumab pegol for Crohn’s disease. N Engl J Med. 2007;357(3):239–50.

    Article  CAS  PubMed  Google Scholar 

  • Schulte CM. Review article: bone disease in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(4):43–9.

    Article  PubMed  Google Scholar 

  • Scott FI, et al. The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model. Clin Gastroenterol Hepatol. 2015;13(2):302–309 e11.

    Article  PubMed  Google Scholar 

  • Shelton E, et al. Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis. Gastroenterology. 2016;151(1):97–109 e4.

    Article  PubMed  Google Scholar 

  • Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol. 2008;64(2):183–99.

    Article  PubMed  Google Scholar 

  • Shi HY, et al. Natural history of elderly-onset ulcerative colitis: results from a territory-wide inflammatory bowel disease registry. J Crohns Colitis. 2016;10(2):176–85.

    Article  PubMed  Google Scholar 

  • Sifuentes H, Kane S. Monitoring for extra-intestinal cancers in IBD. Curr Gastroenterol Rep. 2015;17(11):42.

    Article  CAS  PubMed  Google Scholar 

  • Sinagra E, et al. Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases. Eur J Intern Med. 2013;24(5):385–92.

    Article  CAS  PubMed  Google Scholar 

  • So K. 5-Aminosalicylate (5-ASA) induced nephrotoxicity in inflammatory bowel disease [abstract 638]. Gastroenerology. 2013;144(1):S112.

    Article  Google Scholar 

  • Stuck AE, Frey BM, Frey FJ. Kinetics of prednisolone and endogenous cortisol suppression in the elderly. Clin Pharmacol Ther. 1988;43(4):354–62.

    Article  CAS  PubMed  Google Scholar 

  • Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–4.

    Article  CAS  PubMed  Google Scholar 

  • Tooth L, et al. Weighted multimorbidity indexes predicted mortality, health service use, and health-related quality of life in older women. J Clin Epidemiol. 2008;61(2):151–9.

    Article  PubMed  Google Scholar 

  • Tornatore KM, et al. Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males. J Clin Pharmacol. 1997;37(4):304–11.

    Article  CAS  PubMed  Google Scholar 

  • Toruner M, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134(4):929–36.

    Article  PubMed  Google Scholar 

  • Tsironi E, et al. Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients. J Musculoskelet Neuronal Interact. 2008;8(1):79–84.

    CAS  PubMed  Google Scholar 

  • Turnheim K. Drug therapy in the elderly. Exp Gerontol. 2004;39(11–12):1731–8.

    Article  CAS  PubMed  Google Scholar 

  • van Deen WK, et al. A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20(10):1747–53.

    Article  PubMed  Google Scholar 

  • White-Chu EF, et al. Pressure ulcers in long-term care. Clin Geriatr Med. 2011;27(2):241–58.

    Article  PubMed  Google Scholar 

  • Widdifield J, et al. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res. 2013;65(3):353–61.

    Article  Google Scholar 

  • Zwielehner J, et al. Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol. 2009;44(6–7):440–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine Gastroenterology Division, New York University School of Medicine, New York, NY, USA

    Seymour Katz

  2. Department of Medicine, Division of Gastroenterology and Hepatology, Mount Sinai Beth Israel, New York, NY, USA

    Yingheng Liu

Authors
  1. Seymour Katz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yingheng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seymour Katz .

Editor information

Editors and Affiliations

  1. Saint Peter's Healthcare System, New Brunswick, NJ, USA

    C. S. Pitchumoni

  2. Albert Einstein College of Medicine, Montefiore Medical Center, Wakefield Campus, Bronx, NY, USA

    T.S. Dharmarajan

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Katz, S., Liu, Y. (2020). Challenges in the Management of Inflammatory Bowel Disease. In: Pitchumoni, C., Dharmarajan, T. (eds) Geriatric Gastroenterology. Springer, Cham. https://doi.org/10.1007/978-3-319-90761-1_66-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90761-1_66-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90761-1

  • Online ISBN: 978-3-319-90761-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation